Identifikation und immunologische Charakterisierung von MHC ...

6. Literaturverzeichnis
from the melanomaassociated antigens MART-1 and gp100. J. Immunother.
23(4): 487-498.
Peng, Y., Laouor, MO, Li, EA, Green, A. and Flavell, RA (2004). TGF-β
regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T
cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. USA
101: 4572-4577.
Piali, L., Fichtel, A., Terpe, HJ, Imhof, BA and Gisler, RH (1995). Endothelial
vascular cell adhesion molecule I expression is suppressed by melanoma and
carcinoma. J. Exp. Med. 181: 811-816.
Pieper, R., Christian, RE, Gonzales, MI, Nishimura, MI, Gupta, G., Settlage, RE,
Shabanowitz, J., Rosenberg, SA, Hunt, DF and Topalian, SL (1999).
Biochemical identification of a mutated human melanoma antigen recognized
by CD4(+) T cells. J. Exp. Med. 189: 757-766.
Pieters, J. (1997). MHC class II restricted antigen presentation. Curr. Opin.
Immunol. 9: 89-96.
Powrie, F. and Maloy, KJ (2003). Immunology. Regulating the regulators.
Science 299(5609): 1030-1031.
Qin, Z. and Blankenstein, T. (2000). CD4+ T cell--mediated tumor rejection
involves inhibition of angiogenesis that is dependent on IFN gamma receptor
expression by nonhematopoietic cells. Immunity 12: 677-686.
Radoja, S. and Frey, AB (2000). Cancer-induced defective cytotoxic T
lymphocyte effector function: another mechanism how antigenic tumors
escape immune-mediated killing. Mol. Med. 6: 465-479.
115